Ermenegildo Zegna NV
ZGN
Hutchmed (China)
HCM
Enerpac Tool
EPAC
4
eBay
EBAY
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
TCRR TCR2 Therapeutics
- 1.480
- 0.0000.00%
Trading Jun 2 09:30 ET
58.11MMarket Cap-0.35P/E (TTM)
0.000High0.000Low0Volume0.000Open1.480Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)39.26MShares1.63052wk High0.57P/B41.24MFloat Cap1.48052wk Low--Dividend TTM27.86MShs Float35.860Historical High--Div YieldTTM0.00%Amplitude0.821Historical Low--Avg Price1Lot Size
TCR2 Therapeutics Key Stats
EPS
According to the latest financial report of TCR2 Therapeutics, the latest earnings per share (TTM) for the company is -1.03. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about TCR2 Therapeutics's free cash flow? The latest report shows it as -40.17M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of TCR2 Therapeutics shows that the company's current ratio is 2.96, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of TCR2 Therapeutics, the quick ratio is 2.32, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of TCR2 Therapeutics? The latest ROE figure is -33.36%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of TCR2 Therapeutics, the total asset return on investment (ROA) is -22.46%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check TCR2 Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of TCR2 Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings